Integra LifeSciences Holdings Corp. (IART)
11.91
-0.42
(-3.37%)
USD |
NASDAQ |
Oct 23, 16:00
11.90
-0.01
(-0.08%)
After-Hours: 20:00
Integra LifeSciences Holdings Total Long Term Debt (Quarterly) : 1.988B for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.988B |
| June 30, 2026 | 2.035B |
| March 31, 2026 | 2.026B |
| December 31, 2025 | 1.931B |
| September 30, 2025 | 1.992B |
| June 30, 2025 | 2.000B |
| March 31, 2025 | 2.005B |
| December 31, 2024 | 1.397B |
| September 30, 2024 | 1.974B |
| June 30, 2024 | 1.995B |
| March 31, 2024 | 2.026B |
| December 31, 2023 | 1.666B |
| September 30, 2023 | 1.673B |
| June 30, 2023 | 1.589B |
| March 31, 2023 | 1.597B |
| December 31, 2022 | 1.601B |
| September 30, 2022 | 1.701B |
| June 30, 2022 | 1.703B |
| March 31, 2022 | 1.635B |
| December 31, 2021 | 1.637B |
| September 30, 2021 | 1.639B |
| June 30, 2021 | 1.639B |
| March 31, 2021 | 1.736B |
| December 31, 2020 | 1.643B |
| September 30, 2020 | 1.618B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.186B |
| March 31, 2020 | 1.217B |
| December 31, 2019 | 1.446B |
| September 30, 2019 | 1.526B |
| June 30, 2019 | 1.446B |
| March 31, 2019 | 1.426B |
| December 31, 2018 | 1.354B |
| September 30, 2018 | 1.432B |
| June 30, 2018 | 1.476B |
| March 31, 2018 | 1.832B |
| December 31, 2017 | 1.841B |
| September 30, 2017 | 1.171B |
| June 30, 2017 | 880.00M |
| March 31, 2017 | 855.00M |
| December 31, 2016 | 665.00M |
| September 30, 2016 | 687.75M |
| June 30, 2016 | 705.54M |
| March 31, 2016 | 730.00M |
| December 31, 2015 | 714.97M |
| September 30, 2015 | 729.73M |
| June 30, 2015 | 654.14M |
| March 31, 2015 | 617.05M |
| December 31, 2014 | 630.00M |
| September 30, 2014 | 622.97M |
| June 30, 2014 | 630.97M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Penumbra, Inc. | 198.31M |
| Abbott Laboratories | 0.00 |
| Boston Scientific Corp. | 12.62B |
| Globus Medical, Inc. | 97.53M |
| Sight Sciences, Inc. | 31.45M |